Bullish Moving Averages
16
Bearish Moving Averages
0
Products
Investments
Back Stocks profile
Today’s low
491.20Today’s High
510.5052W low
287.7052W High
510.50Open Price
492.00Prev. Close
468.3000Volume
3489541.00Value
1745468408.20Market Cap Cr
12123.30
Price to Earnings
29.90
Price to Book Value
3.80
Dividend Yield
0.30
PE to Growth
-1.40
Op Revenue TTM Cr
4506.37
Net Profit TTM Cr
405.31
Cash From Operating Activity Cr
439.41
Return on Equity %
12.56
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
03 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
510.07
Second Resistance
519.93
Third Resistance
529.37
First Support
490.77
Second Support
481.33
Third Support
471.47
Relative Strength Index
65.62
Money Flow Index
81.22
MACD
16.31
MACD Signal
16.02
Average True Range
15.44
Average Directional Index
35.52
Rate of Change (21)
13.4
Rate of Change (125)
21.47
Commodity Channel Index
104.2
Williams %R
-18.6
BETA
1 Month
1.38
3 Month
1.31
1 Year
0.97
3 Year
0.31
PRICE CHANGE ANALYSIS
1 Week
Low
High
484.55
510.5
1 Month
Low
High
401.25
510.5
3 Months
Low
High
389.35
510.5
6 Months
Low
High
389.35
510.5
1 Year
Low
High
287.7
510.5
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 943.62 | 985.15 | 1010.66 | 821.44 | 1016.44 | 1031.46 | 967.33 | 925.91 | 917.13 | 894.56 | 707.98 | |
Operating Expenses Qtr | 750.91 | 737.60 | 800.99 | 664.23 | 796.58 | 793.77 | 777.91 | 724.70 | 706.88 | 697.74 | 610.28 | |
Operating Profit Qtr | 189.28 | 246.88 | 208.42 | 156.77 | 217.30 | 238.62 | 185.66 | 196.66 | 205.97 | 192.04 | 93.41 | |
EBIDT Qtr Cr | 192.71 | 247.55 | 209.67 | 157.21 | 219.86 | 237.69 | 189.41 | 201.21 | 210.25 | 196.82 | 97.70 | |
Depreciation Qtr | 36.41 | 36.16 | 36.01 | 35.27 | 37.77 | 38.32 | 34.87 | 34.60 | 31.68 | 31.13 | 31.86 | |
Net Profit Qtr | 97.22 | 142.71 | 116.16 | 79.84 | 125.29 | 139.80 | 108.93 | 124.77 | 129.24 | 121.33 | 46.10 | |
Basic EPS Qtr | 4.01 | 5.89 | 4.80 | 3.30 | 5.18 | 5.75 | 4.39 | 5.03 | 5.21 | 4.89 | 1.86 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 3760.87 | 3941.13 | 3255.95 | 3148.71 | 2336.39 | |
Operating Expenses Annual Cr | 2953.73 | 3092.96 | 2593.79 | 2273.61 | 1815.79 | |
Operating Profit Annual | 801.36 | 838.24 | 644.65 | 861.37 | 494.14 | |
Operating Profit Margin Annual % | 21.31 | 21.27 | 19.80 | 27.36 | 21.15 | |
Total Expenses Annual Cr | 3169.58 | 3277.19 | 2736.30 | 2415.84 | 1944.48 | |
EBIDT Annual Cr | 807.14 | 848.17 | 662.16 | 875.10 | 520.59 | |
EBIDT Annual margin % | 21.46 | 21.52 | 20.34 | 27.79 | 22.28 | |
Depreciation | 143.85 | 145.56 | 126.16 | 118.45 | 101.82 | |
PAT Before ExtraOrdinary Items Annual Cr | 435.92 | 498.79 | 386.51 | 552.78 | 444.07 | |
Net Profit Annual | 435.92 | 498.79 | 386.51 | 552.78 | 444.07 | |
Basic EPS Annual | 18.00 | 20.32 | 15.60 | 22.18 | 17.47 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 3110.95 | 2699.46 | 2530.66 | 2162.62 | 1811.59 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 126.13 | 210.04 | 300.36 | 391.88 | 487.14 | |
Total Current Liabilities Annual Cr | 1768.55 | 1593.77 | 1541.60 | 1128.33 | 847.45 | |
Total Capital Plus Liabilities Annual Cr | 5005.63 | 4503.27 | 4372.62 | 3682.83 | 3146.18 | |
Fixed Assets Annual | 1376.61 | 1393.26 | 1381.36 | 1149.01 | 1056.66 | |
Total Non Current Assets Annual | 2371.70 | 2185.30 | 2041.97 | 1804.97 | 1671.30 | |
Total Current Assets Annual | 2633.92 | 2317.97 | 2330.65 | 1877.87 | 1474.88 | |
Total Assets Annual | 5005.63 | 4503.27 | 4372.62 | 3682.83 | 3146.18 | |
Contingent Liabilities plus Commitments Annual Cr | - | 213.49 | 220.55 | 235.95 | 187.47 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 316.93 | 663.68 | 280.29 | 374.66 | 494.79 | |
Cash from Investing Activity Annual | -302.98 | -96.45 | -318.45 | -232.62 | -164.80 | |
Cash from Financing Annual Activity | 26.14 | -519.47 | 151.43 | -296.21 | -212.29 | |
Net Cash Flow Annual | - | 47.76 | 113.27 | -154.17 | 117.70 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 128.36 | 111.53 | 102.04 | 87.32 | 71.25 | |
ROE Annual % | 14.01 | 18.47 | 15.27 | 25.56 | 24.51 | |
ROCE Annual % | 20.49 | 24.14 | 18.93 | 29.62 | 18.21 | |
Total Debt to Total Equity Annual | 0.34 | 0.34 | 0.41 | 0.39 | 0.44 | |
EBDIT Annual Margin % | 21.49 | 21.57 | 20.44 | 27.91 | 22.53 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 1177.65 | 1156.24 | 1191.02 | 985.86 | 1198.88 | 1147.07 | 1155.52 | 1024.22 | 1033.93 | 1001.64 | 892.68 | |
Operating Expenses Qtr | 920.08 | 905.10 | 976.51 | 848.69 | 967.38 | 914.83 | 907.83 | 808.05 | 837.28 | 823.04 | 737.15 | |
Operating Profit Qtr | 255.70 | 250.48 | 212.97 | 136.82 | 228.12 | 231.29 | 242.91 | 211.50 | 192.70 | 173.73 | 151.18 | |
EBIDT Qtr Cr | 257.57 | 251.13 | 214.50 | 137.17 | 231.49 | 232.24 | 247.70 | 216.17 | 196.66 | 178.60 | 155.53 | |
Depreciation Qtr | 53.18 | 52.39 | 52.52 | 49.24 | 48.71 | 48.36 | 44.06 | 43.36 | 40.18 | 39.23 | 39.84 | |
Net Profit Qtr | 129.65 | 125.65 | 102.12 | 47.90 | 119.61 | 124.33 | 145.09 | 127.57 | 111.00 | 100.88 | 80.68 | |
Basic EPS Qtr | 5.35 | 5.18 | 4.22 | 1.98 | 4.94 | 5.11 | 5.85 | 5.14 | 4.48 | 4.07 | 3.26 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 4510.77 | 4525.70 | 3782.53 | 3264.42 | 2635.20 | |
Operating Expenses Annual Cr | 3650.39 | 3598.10 | 3042.69 | 2382.31 | 2073.33 | |
Operating Profit Annual | 855.98 | 913.82 | 722.23 | 855.23 | 525.32 | |
Operating Profit Margin Annual % | 18.98 | 20.19 | 19.09 | 26.20 | 19.93 | |
Total Expenses Annual Cr | 3963.54 | 3838.52 | 3224.53 | 2560.06 | 2237.31 | |
EBIDT Annual Cr | 860.38 | 927.60 | 739.84 | 882.11 | 561.87 | |
EBIDT Annual margin % | 19.07 | 20.50 | 19.56 | 27.02 | 21.32 | |
Depreciation | 207.33 | 184.49 | 158.63 | 151.46 | 136.95 | |
PAT Before ExtraOrdinary Items Annual Cr | 405.31 | 516.60 | 412.76 | 549.46 | 309.91 | |
Net Profit Annual | 405.31 | 516.60 | 412.76 | 549.46 | 335.40 | |
Basic EPS Annual | 16.72 | 21.00 | 16.60 | 21.95 | 13.15 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 3225.54 | 2834.91 | 2586.53 | 2173.27 | 1843.72 | |
Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.56 | 0.00 | 0.00 | |
Total Non Current Liabilities Annual Cr | 213.15 | 256.15 | 284.21 | 367.08 | 491.24 | |
Total Current Liabilities Annual Cr | 2082.29 | 1813.50 | 1641.60 | 1173.10 | 893.40 | |
Total Capital Plus Liabilities Annual Cr | 5520.98 | 4904.56 | 4512.90 | 3713.45 | 3228.36 | |
Fixed Assets Annual | 2367.32 | 2150.30 | 1897.41 | 1571.08 | 1498.18 | |
Total Non Current Assets Annual | 2615.93 | 2330.42 | 2007.92 | 1716.45 | 1599.66 | |
Total Current Assets Annual | 2905.05 | 2574.15 | 2504.98 | 1997.00 | 1628.70 | |
Total Assets Annual | 5520.98 | 4904.56 | 4512.90 | 3713.45 | 3228.36 | |
Contingent Liabilities plus Commitments Annual Cr | - | 179.88 | 151.30 | 222.93 | 201.72 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 439.41 | 738.75 | 332.05 | 432.48 | 476.19 | |
Cash from Investing Activity Annual | -360.16 | -191.36 | -380.11 | -277.13 | -160.63 | |
Cash from Financing Annual Activity | 7.66 | -440.29 | 190.00 | -299.31 | -212.85 | |
Net Cash Flow Annual | - | 107.10 | 141.94 | -143.97 | 102.70 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 133.08 | 117.13 | 104.32 | 87.75 | 72.52 | |
ROE Annual % | 12.56 | 18.22 | 15.95 | 25.28 | 18.19 | |
ROCE Annual % | 18.99 | 24.04 | 20.24 | 28.76 | 18.19 | |
Total Debt to Total Equity Annual | 0.38 | 0.37 | 0.42 | 0.39 | 0.43 | |
EBDIT Annual Margin % | 19.09 | 20.55 | 19.65 | 27.24 | 21.62 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C | 1.25 | 74537801 | - | - |
GOVERNMENT PENSION FUND GLOBAL | 1.15 | 74537810 | - | - |
AKASH BHANSHALI | 1.1 | 74537822 | - | - |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
KRISHNA PRASAD CHIGURUPATI | 34.78 | 74537785 | 4.86 | 0 |
CHIGURUPATI UMA DEVI | 3.81 | 74537786 | 0 | 0 |
PRAGNYA CHIGURUPATI | 0.76 | 74537787 | 0 | 0 |
CHIGURUPATI PRIYANKA | 0.75 | 74537788 | 0 | 0 |
TYCHE INVESTMENTS PRIVATE LIMITED | 1.47 | 74537795 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
QUANT MUTUAL FUND - QUANT HEALTHCARE FUND | 2.2 | 74537800 |
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C | 1.25 | 74537801 |
FIDELITY FUNDS - INDIA FOCUS FUND | 2.61 | 74537807 |
FIDELITY FUNDS - ASIAN SMALLER COMPANIES POOL | 1.51 | 74537808 |
SCHRODER INTERNATIONAL SELECTION FUND GLOBAL EMERG | 1.46 | 74537809 |
GOVERNMENT PENSION FUND GLOBAL | 1.15 | 74537810 |
AB SICAV I - INTERNATIONAL HEALTH CARE PORTFOLIO | 1.05 | 74537811 |
LIFE INSURANCE CORPORATION OF INDIA | 2.94 | 74537803 |
Name | Holding Percent | Holding Id |
---|---|---|
AKASH BHANSHALI | 1.1 | 74537822 |
HUF | 0.55 | 74537814 |
MAHIMA STOCKS PRIVATE LIMITED | 1.13 | 74537819 |
BASAVA SANKARARAO KOLLI | 1.2 | 74537827 |
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Aug 03, 2023 | 1.5 | FINAL | Aug 03, 2023 | Equity Share |
Jul 19, 2022 | 0.75 | FINAL | - | Equity Share |
Feb 17, 2022 | 0.25 | INTERIM | Feb 18, 2022 | Equity Share |
Nov 24, 2021 | 0.25 | INTERIM | Nov 25, 2021 | Equity Share |
Aug 05, 2021 | 0.25 | INTERIM | Aug 06, 2021 | Equity Share |
Jul 28, 2021 | 0.75 | FINAL | - | Equity Share |
Feb 08, 2021 | 0.25 | INTERIM | Feb 09, 2021 | Equity Share |
Oct 28, 2020 | 0.25 | INTERIM | Oct 30, 2020 | Equity Share |
Aug 05, 2020 | 0.25 | FINAL | - | Equity Share |
Jul 28, 2020 | 0.25 | INTERIM | Jul 29, 2020 | Equity Share |
Jan 30, 2020 | 0.25 | INTERIM | Jan 31, 2020 | Equity Share |
Oct 31, 2019 | 0.25 | INTERIM | Nov 02, 2019 | Equity Share |
Aug 21, 2019 | 0.25 | FINAL | - | Equity Share |
Aug 08, 2019 | 0.25 | INTERIM | Aug 09, 2019 | Equity Share |
Feb 07, 2019 | 0.25 | INTERIM | Feb 08, 2019 | Equity Share |
Nov 06, 2018 | 0.25 | INTERIM | Nov 10, 2018 | Equity Share |
Aug 29, 2018 | 0.25 | FINAL | - | Equity Share |
Aug 01, 2018 | 0.25 | INTERIM | Aug 02, 2018 | Equity Share |
Feb 20, 2018 | 0.25 | INTERIM | Feb 21, 2018 | Equity Share |
Nov 20, 2017 | 0.25 | INTERIM | Nov 21, 2017 | Equity Share |
Sep 20, 2017 | 0.25 | FINAL | - | Equity Share |
Aug 23, 2017 | 0.25 | INTERIM | Aug 25, 2017 | Equity Share |
Feb 07, 2017 | 0.25 | INTERIM | Feb 08, 2017 | Equity Share |
Nov 03, 2016 | 0.2 | INTERIM | Nov 05, 2016 | Equity Share |
Aug 23, 2016 | 0.2 | INTERIM | Aug 24, 2016 | Equity Share |
Aug 03, 2016 | 0.2 | FINAL | - | Equity Share |
Feb 08, 2016 | 0.15 | INTERIM | Feb 09, 2016 | Equity Share |
Nov 09, 2015 | 0.15 | INTERIM | Nov 11, 2015 | Equity Share |
Aug 05, 2015 | 0.15 | INTERIM | - | Equity Share |
Aug 05, 2015 | 0.5 | FINAL | - | Equity Share |
Aug 20, 2014 | 3.5 | FINAL | - | Equity Share |
Aug 08, 2013 | 2 | FINAL | - | Equity Share |
Jun 22, 2012 | 2 | FINAL | - | Equity Share |
Sep 02, 2011 | 1.5 | FINAL | - | Equity Share |
Sep 17, 2010 | 1.25 | FINAL | - | Equity Share |
Sep 18, 2009 | 1.25 | FINAL | - | Equity Share |
Dec 15, 2008 | 1.25 | FINAL | - | Equity Share |
Dec 24, 2007 | 1.25 | FINAL | - | Equity Share |
Dec 21, 2006 | 1.25 | FINAL | - | Equity Share |
Dec 01, 2005 | 1.25 | FINAL | - | Equity Share |
Dec 13, 2004 | 1.25 | FINAL | - | Equity Share |
Sep 18, 2003 | 1 | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Mar 23, 2015 | 10:1 | - |
Ex-Date | Purpose | Notes |
---|---|---|
May 15, 2024 | Audited Results & Final Dividend | - |
Jan 23, 2024 | Quarterly Results | - |
Nov 09, 2023 | Quarterly Results | - |
Aug 09, 2023 | Quarterly Results | - |
May 16, 2023 | Audited Results & Final Dividend | - |
Jan 24, 2023 | Quarterly Results | - |
Oct 20, 2022 | Quarterly Results | - |
Aug 09, 2022 | Quarterly Results & Buy Back of Shares | - |
May 18, 2022 | Audited Results & Final Dividend | - |
Feb 08, 2022 | Quarterly Results & Interim Dividend | - |
Nov 12, 2021 | Quarterly Results & Interim Dividend | - |
Jul 27, 2021 | Quarterly Results & Interim Dividend | - |
May 11, 2021 | Audited Results & Final Dividend | - |
Jan 28, 2021 | Quarterly Results & Interim Dividend | - |
Oct 20, 2020 | Quarterly Results & Interim Dividend | - |
Jul 17, 2020 | Quarterly Results & Interim Dividend | - |
Jun 02, 2020 | Audited Results & Final Dividend | - |
Jan 21, 2020 | Quarterly Results & 3rd Interim Dividend | - |
Oct 22, 2019 | Quarterly Results & Interim Dividend | - |
Jul 30, 2019 | Quarterly Results & 1st Interim Dividend | - |
May 09, 2019 | Audited Results & Final Dividend | - |
Jan 29, 2019 | Quarterly Results & 3rd Interim Dividend | - |
Oct 29, 2018 | Quarterly Results & 2nd Interim Dividend | - |
Jul 23, 2018 | Quarterly Results & 1st Interim Dividend | - |
May 24, 2018 | Audited Results & Final Dividend | - |
Feb 08, 2018 | Quarterly Results & 3rd interim dividend | - |
Nov 09, 2017 | Quarterly Results & 2nd Interim Dividend | - |
Aug 14, 2017 | Quarterly Results & 1st Interim Dividend | - |
Jul 05, 2017 | Others | - |
May 11, 2017 | Audited Results & Final Dividend | - |
Jan 28, 2017 | Quarterly Results & 3rd Interim Dividend | - |
Jan 04, 2017 | Appointment of Director | - |
Oct 25, 2016 | Quarterly Results & 2nd interim dividend | - |
Aug 11, 2016 | Quarterly Results & Interim Dividend | - |
Apr 28, 2016 | Audited Results & Final Dividend | - |
Jan 28, 2016 | Quarterly Results & 3rd Interim Dividend | - |
Dec 10, 2015 | Others | Approved to allot 77,768 equity shares in consequent to exercise of options under ESOP 2009. |
Oct 31, 2015 | Quarterly Results & 2nd Interim Dividend | Approved the resignation of Mr. Harsha Chigurupati as an Executive Director. Mr. Harsha will continue as member of the Board as Non-Executive Director. |
Jul 23, 2015 | Quarterly Results & Interim Dividend | 1. Approved the investment of up to Rs. 20 Crores in GIL Lifesciences Pvt. Ltd., a wholly owned Indian Subsidiary of the Company. 2. Approved the issue of 1,86,56,000 warrants on preferential basis. |
Jun 20, 2015 | Others | To consider the issue of warrants on preferential basis to promoters of the Company. |
Apr 27, 2015 | Audited Results & Final Dividend | The Code of Conduct for prevention of Insider Trading was Amended in line with the SEBI (Prohibition of Insider Trading Regulations) 2015. |
Mar 07, 2015 | Others | To consider and approve the record date for sub-division of shares of face value of Rs.10/- each in to 10 equity shares of Rs.1/- each. |
Jan 28, 2015 | Quarterly Results | - |
Oct 30, 2014 | Quarterly Results | - |
Oct 20, 2014 | Others | To consider the setting up of 100% wholly owned subsidiary outside India. (Revised from 18/10/2014) |
Jul 24, 2014 | Quarterly Results | - |
Apr 24, 2014 | Audited Results & Dividend | - |
Feb 20, 2014 | Others | Approved the Scheme of Arrangement involving amalgamation of Auctus Pharma Limited with Granules India Limited. |
Jan 28, 2014 | Quarterly Results | - |
Oct 30, 2013 | Quarterly Results | - |
Jul 25, 2013 | Quarterly Results | - |
Apr 25, 2013 | Audited Results & Final Dividend | - |
Jan 24, 2013 | Quarterly Results | - |
Oct 25, 2012 | Quarterly Results | - |
Sep 25, 2012 | Quarterly Results | - |
Jul 26, 2012 | Quarterly Results | - |
Apr 24, 2012 | Audited Results, F. Dividend & ESOP | The Board has granted 5,05,000 stock options to Independent Directors & Employees under Stock Option Scheme 2009. |
Jan 24, 2012 | Quarterly Results | - |
Dec 12, 2011 | To approve the working capital limit | To consider and approve the working capital limit and to consider and approve the long term financing facility. |
Oct 17, 2011 | Quarterly Results | (Revised) |
Sep 12, 2011 | Others | - |
Jul 28, 2011 | Quarterly Results | - |
Jul 08, 2011 | Approval of Joint Venture Agreement | For consideration and approval of Joint Venture Agreement. |
Apr 29, 2011 | Audited Results & Final Dividend | - |
Jan 27, 2011 | Quarterly Results | - |
Oct 28, 2010 | Quarterly Results | - |
Jul 26, 2010 | Quarterly Results | - |
May 05, 2010 | Audited Results & Final Dividend | - |
Jan 22, 2010 | Quarterly Results | - |
Oct 26, 2009 | Quarterly Results | - |
Sep 25, 2009 | To approve the Cost Audit Report | inter alia, to approve the Cost Audit Report for the 9 month period ended March 31, 2009. |
Aug 24, 2009 | Employees Stock Option Plan | inter alia, to consider issue of shares to the employees of the Company under the Employee Stock Option Scheme. |
Jul 25, 2009 | Audited, Quarterly Results & Dividend | - |
Apr 25, 2009 | Quarterly Results | - |
Jan 29, 2009 | Quarterly Results | - |
Dec 19, 2008 | To apporve Cost Audit | inter alia, to approve Cost Audit Report for June 2008. |
Oct 20, 2008 | Audited, Qtr. Results & F. Dividend | - |
Jul 31, 2008 | Quarterly Results | (Revised) |
Apr 30, 2008 | Quarterly Results | - |
Jan 24, 2008 | Quarterly Results | - |
Nov 28, 2007 | Audited Results & Final Dividend | - |
Oct 27, 2007 | Quarterly Results | - |
Jul 30, 2007 | Quarterly Results | - |
May 09, 2007 | Preferential Issue | Inter alia, to consider the issue of equity shares on preferential basis subject to the approval of the shareholders of the Company. |
Apr 30, 2007 | Quarterly Results | - |
Feb 25, 2007 | To consider issue of equity shares | Inter alia, to consider the "Issue of equity shares to Investor(s) on preferential basis" subject to the approval of the shareholders of the Company. |
Jan 19, 2007 | Quarterly Results | - |
Nov 09, 2006 | To consider raising of funds | Issue of Convertible Securities / GDRs / ADRs / FCCBs for raising of funds to the tune of USD 20 million. |
Oct 16, 2006 | Accounts, F. Dividend & Qtr. Results | - |
Jul 22, 2006 | Quarterly Results | - |
Apr 21, 2006 | Quarterly Results | - |
Jan 23, 2006 | Quarterly Results | - |
Nov 05, 2005 | Issue of share warrants | - |
Oct 21, 2005 | Quarterly Results | - |
Sep 17, 2005 | Accounts & Final Dividend | - |
Jul 30, 2005 | Quarterly Results | - |
Apr 28, 2005 | Quarterly Results | - |
Jan 29, 2005 | Quarterly Results | - |
Nov 15, 2004 | Accounts & Final Dividend | - |
Oct 29, 2004 | Others | Increase in Authorised Capital & Issue of GDR's or other financial Instruments/securities. |
Jul 30, 2004 | Quarterly Results | - |
Jun 28, 2004 | Dividend & Accounts | - |
Apr 06, 2004 | Preferential Issue of shares | To consider the issue of shares through private placement by way of preferencial allotment. |
Jan 19, 2004 | Quarterly Results | - |
Oct 14, 2003 | Quarterly Results | - |
Jul 24, 2003 | Quarterly Results | - |
Jun 07, 2003 | A.G.M., Dividend & Others | Appointment of additional Director |
May 24, 2003 | Accounts | - |
Jan 21, 2003 | Quarterly Results | - |
Feb 16, 2002 | Preferential Offer | To consider the preferential isue of equity shares to the promoter C. Krishna Prasad. |
Ex-Date | Bonus Ratio | Record Date |
---|
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor MeetGranules India Promoter Pares Stake For Rs 303 Crore
The promoter sold 75 lakh shares, representing 3.09% stake, for Rs 405.08 per share, according to block deal data on the NSE.GRANULES INDIA LTD.-$ - 532482 - Transcript Of The Earnings Conference Call For Q4 And Financial Year Ended On March 31, 2024.
Transcript of the Earnings Conference Call for Q4 and Financial Year ended on March 31, 2024Granules India Q4 Results Review - Higher Finished Dosage Sales Drives Earnings: Dolat Capital
Lower demand impacts active pharma ingredient and pharmaceutical formulation intermediate salesGRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of the Earnings Call for Q4 and FY24Q4FY24 Quarterly Result Announced for Granules India Ltd.
Pharmaceuticals company Granules India announced Q4FY24 results: Revenue from Operations of Q4FY24 stood at Rs 11,758 million, a decline of 2% YoY. Formulations including GPI manufactured products grew by 41%. Revenue share from the North America increased to 70% in Q4FY24 as compared to 58% in Q4FY23. Decline in Para API sales volume and price erosion. Active Pharmaceuticals Ingredients (API), Pharmaceutical Formulation Intermediates (PFI), and Finished dosages contribute 14%, 13%, and 73% of revenue from operations respectively for Q4FY24. ROCE is at 16.5% as compared to 21.2% YoY. Net debt stood at Rs 8,421 million and Net debt to EBITDA at 0.98x. Commenting on the results, Dr Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “We had a strong uptick in gross margin for the Q4 and for the full year, with continued growth in formulations share coming from US and Europe as part of our global expansion strategy and a higher contribution from new products. While the fiscal year numbers were below expectations due to cyber incident and low paracetamol demand, we are very excited about the way our strategies for the future are playing out and look forward to the upcoming years.” Result PDFGRANULES INDIA LTD.-$ - 532482 - Book Closure Date For The Purpose Of Annual General Meeting
Book Closure Date for the purpose of the Annual General MeetingGRANULES INDIA LTD.-$ - 532482 - Record Date For Payment Of Final Dividend For FY2023-24
Record Date for payment of Final Dividend for FY2023-24The latest market price of Granules India Ltd. on NSE was Rs. 500.20 as of today.
The opening share price of Granules India Ltd. was Rs. 492.00 as of today.
The 52-week high share price of Granules India Ltd. was Rs. 510.50.
The 52 week low share price of Granules India Ltd. was Rs. 287.70.
Granules India Ltd. has a market cap of Rs. 12123.30 crore as of today. Please refer to the Fundamentals section for further details.
The PE ratio of Granules India Ltd. is -1.40. Please refer to the Fundamentals section for further details.
The operating revenue for Granules India Ltd. in the last FY was Rs. 4506.37 crore. Please refer to the Financials section for further details.
The Net Profit for Granules India Ltd. in the last FY was Rs. 405.31 crore. Please refer to the Financials section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Granules India Ltd. was on 2023-08-03 for Rs. 1.5 per share. According to today’s share price, the dividend yield of Granules India Ltd. stands at 0.30. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Granules India Ltd. was as of 2015-03-23. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Granules India Ltd..